Distinguishing appropriate from inappropriate conditions on research participation.

Individuals do not have a right to participate in clinical trials. But, they do have a right against being denied participation for inappropriate reasons. Despite the widespread endorsement of these two claims, there has been little discussion regarding which conditions for participation in clinical...

Full description

Bibliographic Details
Published in:Bioethics Vol. 37; no. 2; pp. 135 - 146
Main Authors: Steel, Robert, Wendler, David
Format: Article
Published: Wiley-Blackwell Feb2023
Subjects:
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=161472461&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 161472461
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        02699702
        6PJ
      jtl: Bioethics
      issn: 02699702
      maglogo: Y
    pubinfo:
      dt: Feb2023
      vid: 37
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        161472461
        10.1111/bioe.13092
      ppf: 135
      ppct: 11
      formats:
      tig:
        atl: Distinguishing appropriate from inappropriate conditions on research participation.
      aug:
        au:
          Steel, Robert
          Wendler, David
        affil:
          Department of Philosophy, University of Nebraska at Omaha, Omaha Nebraska,, USA
          Department of Bioethics, NIH Clinical Center, Bethesda Maryland,, USA
      su:
        Clinical trials
        Human research subjects
        Participant-researcher relationships
        Government regulation
        Social values
        Research ethics
        Informed consent (Medical law)
        Patient selection
        Collection & preservation of biological specimens
        Genetic research
      sug:
        subj:
          Clinical trials
          Human research subjects
          Participant-researcher relationships
          Government regulation
          Social values
          Research ethics
          Informed consent (Medical law)
          Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
          Research and development in the physical, engineering and life sciences
          Patient selection
          Collection & preservation of biological specimens
          Genetic research
      keyword:
        genetic research
        human subjects research
        moral theory
        regulatory issues
        research ethics
        genetic research
        human subjects research
        moral theory
        regulatory issues
        research ethics
      ab: Individuals do not have a right to participate in clinical trials. But, they do have a right against being denied participation for inappropriate reasons. Despite the widespread endorsement of these two claims, there has been little discussion regarding which conditions for participation in clinical trials are appropriate and which are inappropriate. The present manuscript attempts to address this gap in the literature. We first describe and then argue against the claim that conditions on enrollment or continued participation are appropriate only when they are needed to answer the scientific question(s) posed by the trial. We then offer an alternative view according to which the appropriateness of conditions depends on whether they help to satisfy the ethical requirements of clinical research. Because these requirements include social value, the present view implies that promoting social value is an acceptable reason to impose conditions on research participation. With this in mind, we explain why it is not coercive to require potential participants to accept conditions on enrollment that promote a trial's social value, even when the participants find those conditions unwelcome. We conclude by evaluating the present proposal's implications for the common practice of requiring participants to agree to the possible use of their leftover biospecimens in a broad range of future research. We argue, contra current regulatory policy, that this practice can be acceptable even when the present trial offers participants the prospect of clinical benefit and the samples are being reserved for future research that is unrelated to the present trial.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N